RxSight, Inc. (RXST)
5.78
-1.00
(-14.75%)
USD |
NASDAQ |
May 07, 11:45
RxSight SG&A Expense (TTM) : 112.65M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Alphatec Holdings, Inc. | 371.51M |
| Abbott Laboratories | 13.01B |
| Accuray, Inc. | 88.55M |
| Boston Scientific Corp. | 7.072B |
| Plus Therapeutics, Inc. | 12.13M |